Dianthus files to sell 23.66M shares of common stock for holders
PremiumThe FlyDianthus files to sell 23.66M shares of common stock for holders
1M ago
Dianthus Therapeutics Appoints Steven Romano to Board
Premium
Company Announcements
Dianthus Therapeutics Appoints Steven Romano to Board
2M ago
Dianthus price target lowered to $36 from $38 at Wedbush
Premium
The Fly
Dianthus price target lowered to $36 from $38 at Wedbush
3M ago
Dianthus initiated with an Overweight at Cantor Fitzgerald
PremiumThe FlyDianthus initiated with an Overweight at Cantor Fitzgerald
5M ago
Dianthus announces FDA clearance to initiate Phase 2 trial of DNTH103
Premium
The Fly
Dianthus announces FDA clearance to initiate Phase 2 trial of DNTH103
5M ago
Dianthus initiated with an Outperform at LifeSci Capital
Premium
The Fly
Dianthus initiated with an Outperform at LifeSci Capital
5M ago
Dianthus price target raised to $38 from $33 at Wedbush
PremiumThe FlyDianthus price target raised to $38 from $33 at Wedbush
6M ago
Dianthus reports Q1 EPS (54c), consensus (44c)
Premium
The Fly
Dianthus reports Q1 EPS (54c), consensus (44c)
6M ago
Dianthus price target raised to $51 from $34 at Raymond James
Premium
The Fly
Dianthus price target raised to $51 from $34 at Raymond James
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100